Companies /Healthcare
Baxter International Inc
NYSE: BAX Medical Instruments & Supplies
$25.39
▲ $0.00 (+0.00%) today
Markets closed · 12:35am ET

Baxter International (BAX) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
BAX vs Market · 30-day return after each reportBAXS&P 500
−5%0%+5%+10%+11.1%+1.3%Q2 25−1.7%+0.3%Q3 25−5.8%−1.5%Q4 25+6.3%+5.7%Q1 26−2.8%+3.4%Q2 26
−5%0%+5%+10%Q2 25Q3 25Q4 25Q1 26Q2 26
BAX EPS Trend · estimate vs actualEstimateActual
$0.00$0.20$0.40$0.60$0.61$0.59Q2 25$0.60$0.69Q3 25$0.54$0.44Q4 25$0.31$0.36Q1 26$0.37$0.56Q2 26$0.52$0.58Q3 26
$0.00$0.20$0.40$0.60Q2 25Q4 25Q2 26
BAX Revenue Trend · estimate vs actualEstimateActual
$0$900.0M$1.8B$2.7B$2.8B$2.8BQ2 25$2.9B$2.8BQ3 25$2.8B$3.0BQ4 25$2.6B$2.7BQ1 26$2.8B$3.0BQ2 26$2.9B$3.0BQ3 26
$0$900.0M$1.8B$2.7BQ2 25Q4 25Q2 26

How Often Does Baxter International Beat Earnings Estimates?

Baxter International beat EPS estimates in 4 of its last 6 reported quarters, and has beaten 3 quarters in a row.

BAX quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Adjusted figure excludes a $253 million pre-tax gain on debt extinguishment ($0.38 per share), intangible amortization of $145 million pre-tax ($0.21), business optimization charges of $61 million ($0.09), business transformation costs of $20 million ($0.03), a $27 million net legal benefit ($0.04), and $41 million of tax matters ($0.08); GAAP diluted EPS was $0.57. $0.58 est. $0.52 +11.93% $3.0B est. $2.9B +2.33%
Q2 2026 $0.56 est. $0.37 +52.51% $3.0B est. $2.8B +5.88%
Q1 2026 $0.36 est. $0.31 +15.90% $2.7B est. $2.6B +3.27%
Q4 2025 $0.44 est. $0.54 −17.80% $3.0B est. $2.8B +5.28%
Q3 2025 $0.69 est. $0.60 +15.40% $2.8B est. $2.9B −1.47%
Q2 2025 $0.59 est. $0.61 −3.12% $2.8B est. $2.8B −0.45%

Figures from SEC filings and company reports. Not investment advice.